The biggest investment story of 2013

It was the greatest investment story in the history of biotechnology. Sunday, August 11th, 2013   Dear Daily Reckoning Reader, According to our colleague and affiliate at The Oxford Club, Laura Cadden… "It was the greatest investment story in the history of biotechnology. A tiny biotech company was founded. Nobel Prize-winning research was transformed into world-changing medicine. Along the way, the stock went on an epic run… from $3.08 to over $240 a share… "Missed that opportunity? So did we… But not this time. Because we've found the NEXT greatest biotech story. With new medicines that are nothing short of awe-inspiring… More importantly, the share price could skyrocket on upcoming news from clinical trial results…" Laura agreed to share their research on this, for free, if you're interested… To check it out, go here right now. Sincerely, Joseph Schriefer Publisher, Agora Financial P.S. Laura tells me that to make the most out of this rare opportunity, you need to act fast. Check it out now.       The Daily Reckoning is committed to protecting and respecting your privacy. We do not rent or share your email address. To end your Daily Reckoning e-mail subscription and associated external offers sent from Daily Reckoning, feel free to click here to unsubscribe. Please read our Privacy Statement. For any further comments or concerns please email us at dr@dailyreckoning.com. If you are you having trouble receiving your Daily Reckoning subscription, you can ensure its arrival in your mailbox by whitelisting the Daily Reckoning. © 2013 Agora Financial, LLC. 808 Saint Paul Street, Baltimore MD 21202. A lthough our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investment advice. We expressly forbid our writers from having a financial interest in any security they personally recommend to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of a printed-only publication prior to following an initial recommendation.Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.